Upstream Bio Financials
| UPB Stock | 30.02 1.77 5.57% |
Please note, the presentation of Upstream Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Upstream Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Upstream Bio's management manipulating its earnings.
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US91678A1079 |
| Business Address | 890 Winter Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | upstreambio.com |
| Phone | 781 208 2466 |
Upstream Bio Key Financial Ratios
Upstream Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Upstream Bio's current stock value. Our valuation model uses many indicators to compare Upstream Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Upstream Bio competition to find correlations between indicators driving Upstream Bio's intrinsic value. More Info.Upstream Bio is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Upstream Bio's earnings, one of the primary drivers of an investment's value.About Upstream Bio Financials
What exactly are Upstream Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Upstream Bio's income statement, its balance sheet, and the statement of cash flows. Potential Upstream Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Upstream Bio investors may use each financial statement separately, they are all related. The changes in Upstream Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Upstream Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Upstream Bio January 24, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Upstream Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Upstream Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Upstream Bio based on widely used predictive technical indicators. In general, we focus on analyzing Upstream Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Upstream Bio's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.9 | |||
| Information Ratio | 0.0966 | |||
| Maximum Drawdown | 24.37 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 7.84 |
Complementary Tools for Upstream Stock analysis
When running Upstream Bio's price analysis, check to measure Upstream Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio is operating at the current time. Most of Upstream Bio's value examination focuses on studying past and present price action to predict the probability of Upstream Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio's price. Additionally, you may evaluate how the addition of Upstream Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges |